http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1933861-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ff40e5f9fe4a871b3c1ef0cdccfa05a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-565
filingDate 2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b191249a5d65de194dd6a611ac04078a
publicationDate 2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1933861-A1
titleOfInvention Method for treating or preventing ischemia reperfusion injury or multi-organ failure
abstract This invention concerns the use of a therapeutically active agent for the manufacture of a pharmaceutical preparation useful in a method for prevention or treatment of ischemia reperfusion injury or multi-organ failure in an individual. According to the invention, said agent is plain interferon beta and said agent is intended for use without simultaneous administration of one or more agent affecting the adenosine level in individual.
priorityDate 2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100429-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03024399-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084933-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23615235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740296

Total number of triples: 39.